** Shares of healthcare tech firm Veeva Systems VEEV.N
rise 4.8% to $209 premarket
** Company sees FY revenue between $2.70 bln - $2.71 bln,
above Wall Street estimate of $2.68 bln - LSEG data
** Forecasts FY adj EPS of $6.22 vs market expectations of
$6.14
** Q2 revenue of $676.2 mln beat average analysts' estimate
of $668.4 mln
** VEEV posts quarterly adj EPS of $1.62, above consensus of
$1.53
** At least eight brokerages raise their price target on
VEEV following Q2 results
** 19 of 29 brokerages rate the stock "buy" or higher, nine
"hold" and one "sell"; their median PT is $233
** Up to Wednesday's close, stock had risen 3.6% YTD
(Reporting by Khushi Singh in Bengaluru)
((Khushi.Singh@thomsonreuters.com))